Evidence map›Paper›PMID 24816093›Full record

ArticleActa crystallographica. Section D, Biological crystallography2014

Accurate macromolecular crystallographic refinement: incorporation of the linear scaling, semiempirical quantum-mechanics program DivCon into the PHENIX refinement package.

Oleg Y Borbulevych, Joshua A Plumley, Roger I Martin, Kenneth M Merz, Lance M Westerhoff

Abstract read
In one paragraph

Article in Acta crystallographica. Section D, Biological crystallography, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. fragHAR: towardsIUCrJ · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Validation of ligands in macromolecular structures determined by X-ray crystallography.Acta crystallographica. Section D, Structural biology · 2018
    Article
  17. Solving the scalability issue in quantum-based refinement: Q|R#1.Acta crystallographica. Section D, Structural biology · 2017
    Article
  18. Review
  19. Quantum crystallography.Chemical science · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Oleg Y BorbulevychQuantumBio Inc., 2790 West College Avenue, State College, PA 16801, USA.
Joshua A PlumleyQuantumBio Inc., 2790 West College Avenue, State College, PA 16801, USA.
Roger I MartinQuantumBio Inc., 2790 West College Avenue, State College, PA 16801, USA.
Kenneth M MerzQuantum Theory Project, University of Florida, Gainesville, Florida USA.
Lance M WesterhoffQuantumBio Inc., 2790 West College Avenue, State College, PA 16801, USA.

Funding

Enhancement and Deployment of the Quantum Mechanical X-ray Refinement ModelR44GM079899 · NIGMS · QUANTUMBIO, INC. · PI WESTERHOFF, LANCE M · 2008 to 2010
$1.4M
NIGMS NIH HHS 1R42GM079899NIGMS NIH HHS R44 GM079899
6 · The paper itself

Abstract

Macromolecular crystallographic refinement relies on sometimes dubious stereochemical restraints and rudimentary energy functionals to ensure the correct geometry of the model of the macromolecule and any covalently bound ligand(s). The ligand stereochemical restraint file (CIF) requires a priori understanding of the ligand geometry within the active site, and creation of the CIF is often an error-prone process owing to the great variety of potential ligand chemistry and structure. Stereochemical restraints have been replaced with more robust functionals through the integration of the linear-scaling, semiempirical quantum-mechanics (SE-QM) program DivCon with the PHENIX X-ray refinement engine. The PHENIX/DivCon package has been thoroughly validated on a population of 50 protein-ligand Protein Data Bank (PDB) structures with a range of resolutions and chemistry. The PDB structures used for the validation were originally refined utilizing various refinement packages and were published within the past five years. PHENIX/DivCon does not utilize CIF(s), link restraints and other parameters for refinement and hence it does not make as many a priori assumptions about the model. Across the entire population, the method results in reasonable ligand geometries and low ligand strains, even when the original refinement exhibited difficulties, indicating that PHENIX/DivCon is applicable to both single-structure and high-throughput crystallography.

Indexed as

Crystallography, X-RayModels, MolecularDatabases, FactualDatabases, ProteinHigh-Throughput Screening AssaysImage Processing, Computer-AssistedLigandsMacromolecular SubstancesProteinsQuantum TheoryReproducibility of ResultsSoftwareStereoisomerismLigandsMacromolecular SubstancesProteinshigh-throughput crystallographyligand strainquantum-mechanics refinementregional refinementstereochemical restraintsX-ray crystallography

Identifiers

PMID24816093
PMCPMC4014119

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.